Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

0
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Category

Show more Refine

For: Herrera AS, Beeraka NM, Sinelnikov MY, Nikolenko VN, Giller DB, Solis LFT, Mikhaleva LM, Somasundaram SG, Kirkland CE, Aliev G. The Beneficial Effects of QIAPI 1® against Pentavalent Arsenic-Induced Lung Toxicity a Hypothetical Model for SARS CoV2-Induced Lung Toxicity. Curr Pharm Biotechnol 2021;23:307-315. [PMID: 33845734 DOI: 10.2174/1389201022666210412142230] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Revised: 01/12/2021] [Accepted: 02/16/2021] [Indexed: 11/22/2022]

For:	Herrera AS, Beeraka NM, Sinelnikov MY, Nikolenko VN, Giller DB, Solis LFT, Mikhaleva LM, Somasundaram SG, Kirkland CE, Aliev G. The Beneficial Effects of QIAPI 1® against Pentavalent Arsenic-Induced Lung Toxicity a Hypothetical Model for SARS CoV2-Induced Lung Toxicity. Curr Pharm Biotechnol 2021;23:307-315. [PMID: 33845734 DOI: 10.2174/1389201022666210412142230] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2020] [Revised: 01/12/2021] [Accepted: 02/16/2021] [Indexed: 11/22/2022]

No articles found.

(The first 100,000 artilces are displayed in RCA.)